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Abstract
Osteochondral defects of the ankle are common lesions affecting the talar cartilage and subchondral
bone. Current treatments include cell-based therapies but are frequently associated with donor-site
morbidity. Our objective is to characterize the posterior process of the talus (SP) and the os trigonum
(OT) tissues and investigate their potential as a new source of viable cells for application in tissue en-
gineering and regenerative medicine. SP and OT tissues obtained from six patients were characterized
by micro-computed tomography and histological, histomorphometric and immunohistochemical
analyses. Proliferation and viability of isolated cells were evaluated by MTS assay, DNA quantiﬁcation
and live/dead staining. The TUNEL assaywas performed to evaluate cell death by apoptosis. Moreover,
the production of extracellular matrix was evaluated by toluidine blue staining, whereas cells
phenotype was investigated by ﬂow cytometry. Characterization of ankle explants showed the
presence of a cartilage tissue layer in both SP and OT tissues, which represented at least 20%, on
average, of the explant. The presence of type II collagen was detected in the extracellular matrix.
Isolated cells presented a round morphology typical of chondrocytes. In in vitro studies, cells were
viable and proliferating for up to 21days of culture. No signs of apoptosis were detected. Flow-
cytometry analysis revealed that isolated cells maintained the expression of several chondrocytic
markers during culture. The results indicated that the SP and OT tissues were a reliable source of
viable chondrocytes, which could ﬁnd promising applications in ACI/MACI strategies with minimal
concerns regarding donor zone complications. Copyright © 2015 John Wiley & Sons, Ltd.
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1. Introduction
Osteochondral defects (OCDs) of the ankle represent 4%
of all osteochondral lesions in the body (Reddy et al.,
2007). Ankle OCDs affecting both the talar cartilage and
subchondral bone are mostly caused by single or multiple
traumatic events. These types of lesions frequently prog-
ress to partial or complete detachment of the fragment,
causing deep ankle pain, especially if associated with
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weight bearing (Qiu et al., 2003). Impaired function, lim-
ited range of motion, stiffness, catching, locking and swell-
ing have been described as the most signiﬁcant associated
problems (van Dijk et al., 2010; Zengerink et al., 2010).
Although some OCDs of the ankle are asymptomatic,
these can progress to cartilage degeneration and osteoar-
thritis, thus being a major concern in orthopaedics
(Schachter et al., 2005). In this case, conservative treat-
ment is restricted to stable defects in young patients
(Anders et al., 2012). In turn, symptomatic OCDs that
extend to bone often require surgical treatment in order
to restore physiological joint function and prevent the pro-
gression of secondary degeneration (O’Driscoll, 1998). In
each clinical situation, the choice of the surgical technique
to be employed depends on various factors, such as the
size of the lesion, site of injury and activity and age of
the patient (Valderrabano et al., 2013; Vasiliadis and
Wasiak, 2010). Techniques such as abrasion and drilling
are considered by the surgeon only in a few particular
cases (Vasiliadis and Wasiak, 2010). Microfracture is a
widely used technique and it is considered the treatment
of choice for the healing of small OCDs, i.e. not exceeding
1.5 cm2 (Valderrabano et al., 2013). In this particular
condition, the use of mosaicplasty, namely osteochondral
autotransplantation, is also supported (Valderrabano
et al., 2009).
For larger lesions and/or patients with moderate to
high activity, new approaches using techniques inspired
by regenerative medicine principles have been applied,
showing promising results (Giannini et al., 2008; Giza
et al., 2010; Gobbi et al., 2006). One of the most encour-
aging treatments comprises cell-based therapies, such as
autologous chondrocyte implantation (ACI). Based on tis-
sue engineering (TE) techniques, implantation of matrix-
associated cells has also been attempted, using stem cells
(MASI) or chondrocytes (MACI), either at the ankle or
knee (Schneider and Karaikudi, 2009; Zengerink et al.,
2010). In fact, TE of the ankle has been attracting a great
deal of interest (Correia et al., 2014). Although promising,
the MASI approach still requires better control of stem
cells chondrogenic differentiation in vivo as compared to
MACI. Therefore, the latter has been more widely applied.
The main advantage of MASI over MACI is that it may
require a one-step (Giannini et al., 2009) instead of the
two-step procedure, thus eliminating the cost and time-
consuming process of culture expansion.
For procedures using chondrocytes, the cells are com-
monly harvested from the healthy cartilage (Candrian
et al., 2010), usually from the ipsilateral knee or from the
anterior part of the talus (Baums et al., 2006), and are
further expanded in vitro (Vasiliadis and Wasiak, 2010).
In a second stage, chondrocytes are implanted in the
defect directly or after ’seeding’ into a three-dimensional
(3D) porous matrix or scaffold (Valderrabano et al.,
2013; Vannini et al., 2013; Vasiliadis and Wasiak, 2010).
However, this technique is frequently associated with pain
at the donor site (Reddy et al., 2007; Valderrabano et al.,
2009) and is detrimental to the function of the ankle joint
(Candrian et al., 2010). Up to 50% incidence of knee pain
has been described post-transplant of donor knee–ankle
(Reddy et al., 2007; Valderrabano et al., 2009). A conve-
nient approach would be the utilization of chondrocytes
isolated from OCDs that are usually harvested during
surgery. In fact, it was reported that these chondrocytes
can be used in ACI or MACI techniques with good clinical
results (Giannini et al., 2005). However, the chondrogenic
capacity of chondrocytes isolated from OCDs remains
controversial, since it has been reported that the formed
tissue contains an inferior amount of glycosaminoglycan
and type II collagen and a superior amount of type I
collagen (Kuroki et al., 2002), as well as a reduced
cartilage-forming capacity (Candrian et al., 2010). There-
fore, this approach does not seem to be the most adequate
strategy when envisioning the treatment of ankle OCDs, at
least for now.
The posterior process of the talus, also known as
Stieda’s process, can be associated with the syndrome
of posterior impingement of the talus, especially in ath-
letes and ballet dancers (Bizarro, 1921; Russell et al.,
2010). Its clinical management requires arthroscopic sur-
gery, in which Stieda’s process is removed (Park et al.,
2013). Also described in the literature is the existence
of an accessory bone, the os trigonum, which is associ-
ated with the posterior process of the talus and has no
deﬁned function. Nevertheless, it has been frequently
associated with chronic complaints related to plantar
ﬂexion mechanisms (Bizarro, 1921). In the symptomatic
posterior ankle impingement syndrome, the removal of
these structures has been described and proposed for
pain management (Park et al., 2013; Russell et al.,
2010). The orthopaedic community assumes that the
arthroscopic excision of these structures is not associated
with signiﬁcant morbidity (Chao, 2004). Due to the
minimally invasive surgery generally used during its
excision (Tey et al., 2007; van Dijk et al., 2000), this
tissue could be seen as a potential valuable source of
cells for ACI or MACI procedures.
To our knowledge, there are no reports on the biologi-
cal characterization of the posterior talus process or
the os trigonum, so basic studies are greatly needed.
This work aims to characterize the posterior process
of the talus and os trigonum tissues in order to achieve
a new source of viable cells for use in tissue-
engineering approaches and treatment of OCDs of the
ankle. The biological tissue from six patients who
underwent excision of the osteochondral fragments
was characterized in terms of tissue architecture, com-
position of extracellular matrix and cellularity by
micro-computed tomography (micro-CT) analysis, immu-
nohistochemistry and histomorphometric analysis, respec-
tively. Moreover, cells isolated from the extracted tissue
were evaluated in vitro, for up to 21days of culture, regard-
ing their proliferation ability, viability and occurrence of
cell apoptosis by DNA quantiﬁcation, live/dead and MTS
assay and TUNEL reaction method, respectively. Cells were
also characterized regarding the expression of speciﬁc sur-
face markers by ﬂow cytometry, in order to determine cells
phenotype.
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2. Materials and methods
2.1. Biological samples
Human tissues were obtained through cooperation proto-
cols established with Centro Hospitalar Póvoa do Varzim
and do Dragão. The study was approved by the Ethical
Committee of Centro Hospitalar Póvoa do Varzim and the
University of Minho. The ankle tissues comprising the
posterior process of the talus (SP), os trigonum (OT) and
normal ankle articular cartilage (AJ) (see supporting
information, Figure S1) were obtained from different age
and sex donors by means of surgical technique. It was
guaranteed that patients were enrolled for surgery
(excision of osteochondral fragment) regardless of study
participation. Patients received information about the
procedure and were selected to participate in the study
after obtaining their informed consent in written form.
There was no interference in the ordinary course of treat-
ment. Biological samples (n=6) were then selected for
tissue (n=3) and cellular (n=3) characterization. The
samples were classiﬁed as OT or SP, as indicated by the
surgeon. One of the samples was obtained from the AJ,
and it was also processed for biological characterization
according to the established protocols for OT and SP. The
tissue was maintained in a phosphate-buffered saline
(PBS; Sigma) solution containing 1% v/v antibiotic–
antimycotic mixture (AB; Gibco) and processed within
24h for cell isolation. For studying tissue architecture
and histological studies, the extracted tissues were rinsed
with PBS and ﬁxed in 10% v/v formalin (Bio Optica) for
at least 1 day.
2.2. Tissue characterization
2.2.1. Micro-computed tomography (micro-CT)
analysis
The microstructure of the extracted tissues (n=3) was
qualitatively and quantitatively evaluated by micro-CT
analysis. The structure of the sample was acquired by
X-ray and then reconstructed and analysed. Hard/soft
tissues (approximately corresponding to bone and carti-
lage, respectively) morphometric parameters, such as
porosity, mean pore size, trabecular thickness and
hard/soft tissues proﬁles, were determined. A 3D recon-
struction was also performed in order to characterize the
tissue. Data acquisition was performed in a SkyScan
1072 scanner with a pixel size of 16μm and an integra-
tion time of 1280ms. The X-ray source was set at 82 kV
and 122μA. Approximately 600 projections were ac-
quired over a rotation range of 180°, with a rotation step
of 0.45°. Datasets were reconstructed using standardized
cone-beam reconstruction software (NRecon v. 1.6.6.0,
SkyScan). The output format for each sample was bit-
map images. The set of images was orientated with
DataViewer (v. 1.4.4, SkyScan) to obtain all samples in
the same axis. A representative dataset of the slices
was segmented into binary images with a dynamic
threshold of 40–120 for soft tissue and 120–255 for hard
tissue analysis (grey values). Afterwards, the binary
images were used for morphometric analysis (CT
Analyser, v. 1.12.0.0, SkyScan) and to obtain the 3D
models (CT Vox, v. 2.3.0 r810, SkyScan).
2.2.2. Histological and immunohistochemical
characterization
Specimens (n=3) were decalciﬁed with 10% v/v formic
acid (Panreac) for 2 weeks. After this step, the samples
were processed in a spin tissue processor (STP120-2,
Thermo Scientiﬁc) overnight, which included immersion
in baths of formalin, ascending series of ethanols
(Panreac), xylene (VWR International) and parafﬁn im-
pregnation (Thermo Scientiﬁc). The specimens were
then embedded in parafﬁn and sectioned into 3μm
slices using a microtome (HM 355S, MICROM Interna-
tional GmbH). Three different stainings were per-
formed: haematoxylin and eosin (H&E), Masson’s
trichrome (MT) and toluidine blue (TB). H&E was used
to visualize the tissue structure and architecture, as well
as cellularity. MT and TB were performed to detect ar-
ticular cartilage extracellular matrix components, such
as collagen and glycosaminoglycans, according to previ-
ously described methods (van Dijk et al., 2000). Slides
were then imaged under transmission microscopy
through an Axio Imager.Z1m light microscope (Zeiss)
with an attached digital camera, AxioCam MRc5 (Zeiss),
connected to ZEN blue image processing software
(Zeiss). For immunohistochemistry, sections were
blocked with sodium citrate buffer (10mM sodium
citrate in 0.05% Tween 20; Aldrich) and stained with
the respective two primary antibodies and ﬂuorescent-
labelled secondary antibody (see supporting informa-
tion, Table S1). Counterstaining of cell nuclei was
further performed with 4,6-diamidino-2-phenyindole,
dilactate (DAPI, Sigma). Sections were imaged under
ﬂuorescence microscopy using an AxioCam MRc5 digital
camera (Zeiss) connected to ZEN blue image processing
software (Zeiss) attached to the Axio Imager.Z1m light
microscope (Zeiss).
2.2.3. Histomorphometric analysis
The images obtained from the slides stained with H&E
were used to perform a histomorphometric analysis to
determine the chondrocyte density on cartilage segments.
The WCIF ImageJ software program (US National Insti-
tutes of Health) was used for cell counting. After
subtracting the background, a 12-radius threshold was
used to reduce background noise and automatic cell
counting (nuclei) was performed. A total of 50 photomi-
crographs (700×500μm2)/specimen were analysed
(n=3).
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2.3. Cells biological characterization
2.3.1. Cell isolation and expansion
Chondrocytes populations (n=3) were isolated following
an enzymatic digestion-based method with type II collage-
nase (Sigma) from ankle tissues. The extracted tissue was
placed in PBS solution and washed several times with PBS
containing 1% v/v AB mixture, until total removal of
blood or other bodily contaminants was achieved. Carti-
lage tissue was then separated from bone and, after being
washed several times with PBS solution containing 1%
v/v AB mixture, the cartilage portion was cut into small
pieces. Tissue digestion was performed by incubation at
37 °C in a humidiﬁed atmosphere of 5% CO2 for 1–2h in
10–20ml of a mixture composed of Dulbecco’s modiﬁed
Eagle’s medium F12 (DMEM F12; Gibco), supplemented
with 10% fetal bovine serum (FBS; Gibco), 1% AB mixture
and type II collagenase (1:1). The digested tissue was
ﬁltered and the cell suspension centrifuged at 1220 rpm
for 5min. The isolated cell populations were expanded in
DMEM F12 supplemented with 10% FBS and 1% AB
mixture until conﬂuence was reached. Chondrocytes were
expanded until passage 3 and detached from the T-75 cul-
ture ﬂask using TrypLE Express (Gibco). Polystyrene tissue
culture was performed in a 24-well plate, using cells at
passage 4 with a cell density of 10 000 cells/well. Each
sample was evaluated after speciﬁc periods of culture
(time points, TPs), i.e. 1, 3, 7, 14 and 21days, in triplicate
for each tissue type, and three wells without cells were
used as control. Two independent sets of experiments
were performed.
2.3.2. Cellular viability and proliferation
Cell metabolic activity was assessed by performing MTS [3-
(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-
2(4-sulphofenyl)-2H-tetrazolium] assay (Cell Titer 96®
Aqueous Solution Cell Proliferation Assay, Promega), ac-
cording to the ISO/EN 10993 Part 5 guidelines (ISO/
EN10993-5, 2009). At each TP (i.e. 1, 3, 7, 14 and 21days),
cultured cells were washed with PBS solution and incu-
bated in MTS reagent at 37°C in a 5% CO2 atmosphere
for 3 h in the dark. After incubation, 100μl of each well
(in triplicate) were transferred into a 96-well plate for op-
tical density (OD) measurement at 490nm in a microplate
reader (Molecular Devices). The percentage of cell
viability was calculated after normalization with the mean
OD value obtained for the negative control. OD is directly
proportional to the cellular activity, being a measure of
mitochondrial activity.
Detection and quantiﬁcation of DNA was performed
by using the Quant-i™ PicoGreen® dsDNA Reagent
(Invitrogen). After washing the cells with PBS, 1ml
ultra-pure water was added to each well. The cells were
then mechanically detached from the well and the
suspension was transferred into Eppendorf tubes. After
incubation in a water bath at 37°C for 1 h, the cell sus-
pension was frozen at –80°C for at least 1 h. Afterwards,
the mixture was defrosted in an ultrasonic water bath
(DT100H Sonorex Digitec, Bandelin) for 15min and
transferred in triplicate into a 96-well plate. PicoGreen®
solution was added afterwards in a 1:1 ratio. Fluores-
cence was measured in a microplate reader at ex/em
~480/520nm. λDNA (Invitrogen) was used to prepare
the standard curve.
Cell viability was evaluated by live/dead assay after
culturing the cells in 13mm tissue culture coverslips.
Live cells (stained with calcein AM 2:1000, Gibco;
ex/em ~495/515nm) and dead cells (indicated by
propidium iodide 1:1000, Gibco; ex/em ~495/635nm)
were imaged through a Zeiss Axio Imager.Z1m ﬂuores-
cence microscope.
2.3.3. Cellular apoptosis
The in situ Cell Death Detection Kit (Roche) was used to
detect apoptotic cells, using the terminal deoxynucleotidyl
transferase dUTP nick end labelling (TUNEL) reaction.
Brieﬂy, cells cultured in 13mm tissue culture coverslips
were washed in PBS and ﬁxed in 10% v/v formalin for
1 h at room temperature. Afterwards, the cells were incu-
bated in a permeabilization solution (0.1% Triton X in
0.1% in sodium citrate, Sigma) for 2min on ice. Nega-
tive (without terminal transferase) and positive (with
DNase I recombinant 20 U/ml; Amresco) controls in
50mM Tris(hydroxymethyl) aminomethane (Sigma),
pH7.5, and 1mg/ml bovine serum albumin (Sigma)
were also prepared. For each sample, 50μl TUNEL reac-
tion mixture was added and incubated at 37°C, 5% CO2
for 1 h in the dark, as well as on the positive and nega-
tive controls. Counterstaining with ﬂuorescein phalloidin
(Sigma) and DAPI was also performed. Apoptotic cells
were imaged using a Zeiss Axio Imager.Z1m ﬂuores-
cence microscope (ex/em ~495/515nm) and phalloidin
(ex/em ~540/565nm) and DAPI (ex/em ~358/461nm)
were used to double-check the location of cells and their
nuclei.
2.3.4. Matrix production evaluation
Evaluation of matrix production was performed by tolui-
dine blue O (Betalab) staining at 1% w/v in cells grown
in 13mm tissue culture coverslips for each period of cul-
ture. Images were obtained under transmission micros-
copy through an Axio Imager.Z1m light microscope.
2.3.5. Phenotype characterization
Fluorescence-activated cell sorting (FACS) analysis was
performed to examine surface marker expression on
chondrocytes at passages 2 and 3 following isolation
from cartilage samples (n=3). Cells were tested using
anti-human monoclonal ﬂuorescein isothiocyanate
(FITC)-conjugated mouse CD105 (AbD Serotec), CD90
and CD45 (BD Biosciences) antibodies; phycoerythrin
(PE) conjugated mouse CD73, CD44 and CD34 (BD
Biosciences) antibodies; and allophycocyanin (APC)
S. I. Correia et al.
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conjugated rat CD49f (eBioscience) and mouse CD90
(BD Biosciences) antibodies. All antibodies were used
at concentrations recommended by the manufacturers
for FACS analysis. Brieﬂy, cells frozen at different pas-
sages were thawed, collected in culture media and
counted using the trypan blue exclusion method. A cell
suspension containing a total of 6×105 cells was centri-
fuged for 5min at 300× g and the pellet was resus-
pended in 500μl PBS containing 2% w/v BSA (Sigma).
For direct staining, 1.5×105 cells/tube were incubated
for 15min with ﬂuorochrome-conjugated antibodies at
room temperature in the dark. After incubation, the cells
were washed with PBS/BSA solution, centrifuged for
5min at 1500 rpm, resuspended in PBS and analysed with
counting of a minimum of 40 000 events. Calibrite beads
three-colour kit (BD CaliBRITETM beads, BD Biosciences)
was used to adjust the equipment instrument settings
before running the samples. The data were acquired using
a BD FACSCanto™ (BD Biosciences) ﬂow cytometer.
Labelling experiments were repeated three times.
2.4. Statistical analysis
Statistical analysis was performed using commercial SPSS
software (IBM SPSS Statistics v. 21.0, IBM). ANOVA
Bonferroni was used to assess signiﬁcant differences in
the mean values of cell counting on each sample. Paired
samples t-tests were used to evaluate signiﬁcant differ-
ences in the mean values of absorbance/DNA concentra-
tion between time points. Complementarily, Cohen’s
d-test was used. Signiﬁcant differences between samples
were assessed with ANOVA Bonferroni. In all cases, the
level of signiﬁcance used was set at p<0.05 for a 95%
conﬁdence interval.
3. Results
3.1. Tissue characterization
Two samples of the posterior process of the talus (SP) and
one of the os trigonum (OT) explants were characterized
by micro-computed tomography (micro-CT) analysis and
histology/immunohistochemistry, and were designated
by SP1, SP2 and OT, respectively. The mean age of the pa-
tients was 38±12 years.
The structure of the samples was acquired by X-ray
and then reconstructed and analysed. Hard/soft tissues
(approximately corresponding to bone and cartilage,
respectively) morphometric parameters, such as porosity,
mean pore size, trabecular thickness and hard/soft
tissues proﬁles, were determined. A 3D reconstruction
was also performed in order to characterize the tissue.
The data obtained in micro-CT analysis (Table 1) indi-
cated values of porosities for OT, SP1 and SP2 of 90%,
93% and 98% in hard tissue and 68%, 77% and 76%
in soft tissue, respectively. Mean trabecular thickness in
hard tissue was 242, 214 and 162μm for OT, SP1 and
SP2, respectively. In soft tissue, the values of mean
trabecular thickness were 278, 177 and 251μm for OT,
SP1 and SP2, respectively. Similarly to the parameter of
mean porosity, the pore size was larger in hard tissue
in all samples. For all specimens, the cartilage tissue
represented at least 20% on average. The OT has a
higher percentage of cartilaginous tissue, i.e. 32% as
compared to SP1 and SP2. Interconnectivity was higher
in hard tissue as compared to soft tissue.
Figure 1 shows the micro-CT morphometric analysis of
the human ankle explants. All the explants reached approx-
imately a 50% content in soft tissue (Figure 1A). The distri-
bution of hard tissue trabecular thickness (Figure 1B)
showed that about 36% of the trabecular diameters were
in the range 181.3–280.2μm. From the data obtained for
soft tissue thickness (Figure 1B), it was possible to observe
that around 22% of the diameters were in the range
155.4–181.3μm, which indicated that soft tissue presents
inferior trabecular diameters as compared to hard tissue.
In terms of hard tissue pore size, the proﬁle showed that
the majority of the pores had diameters>80–110μm.
Compared with hard tissue pore size, a higher variation
in pore size values was found in soft tissue for all explants.
Moreover, soft tissue appeared to have two types of pores: a
smaller range<10μm and a larger range of pores that
started at approximately 50μm and reached>100μm.
Figure 2 shows 2D (X-ray) and 3D reconstructed images
of the human ankle OT and SP explants. It is possible to
observe two distinct regions, corresponding to cartilage
(external part) and bone (core region) tissues.
Figure 3 shows optical microscopy images with differ-
ent staining for each specimen. H&E staining was used
to visualize the tissue structure and architecture, as well
as cellularity; MT and TB staining revealed the presence
of negatively charged glycosamicoglycans and proteogly-
cans within the cartilage. The deposition of type II
collagen was also detected on cartilage tissue by immu-
nohistochemical analysis. Although the presence of type
I collagen was also evaluated (see supporting informa-
tion, Figure S2), it was not possible to be detected, due
to the natural ﬂuorescence of the specimens.
The quantiﬁcation of cells in SP and OTwas performed
using WCIF ImageJ software, in order to evaluate chon-
drocyte density within the cartilage in this kind of tissue.
Table 1. Structural properties of hard and soft tissues in three
ankle explants
OT SP1 SP2
Hard tissue/bone
Mean porosity (%) 90 93 98
Mean trabecular thickness (μm) 242 214 162
Mean pore size (μm) 2247 3970 2377
Interconnectivity (%) 92 90 99
Soft tissue/cartilage
Mean porosity (%) 68 77 76
Mean trabecular thickness (μm) 278 177 251
Mean pore size (μm) 1194 2906 2203
Interconnectivity (%) 79 80 84
OT, os trigonum; SP1 and SP2, Stieda’s processes.
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Cell density observed in cartilage had a mean value of 350
±101 cells/mm2 for OT, 204±65 cells/mm2 for SP1 and
342±76 cells/mm2 for SP2 (see supporting information,
Figure S3). Signiﬁcant differences were observed in aver-
age cell counts/mm2 between SP1 and SP2, as well as be-
tween SP1 and OT (p<0.001). No signiﬁcant differences
were observed between SP2 and OT (p>0.5).
3.2. Cells biological characterization
The ages of tissue donors for cell isolations were 35
(SP), 19 (OT) and 23 (AJ) years, with an average age
of 26±7 years. The enzymatic method used for
chondrocytes isolation from the ankle tissues proved
to be reliable, as it consistently permitted to obtain
Figure 1. Micro-CT morphometric analysis of human ankle explants: (A) percentages of soft and hard tissue; (B) trabeculae and pore
size distributions in the hard and soft tissue of the explants; OT, os trigonum; SP, Stieda’s process
S. I. Correia et al.
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viable cells. Isolated cells presented a round morphol-
ogy typical of chondrocytes. At passage 4, cells
cultured for different time periods (i.e. 1, 3, 7, 14 and
21days) exhibited a similar elongated and spindle-
shaped morphology characteristic of dedifferentiated
chondrocytes.
The metabolic activity of the isolated chondrocytes was
quantiﬁed by reduction ofMTS reagent at each culture time
for the three types of tissue (Figure 4A). The results showed
that cells remained metabolically active at each time point
(TP) tested. For each sample, differences between two con-
secutive TPs were signiﬁcant (p<0.05), except for
TP_14d–TP_21d (d=days) on the AJ sample, where no
signiﬁcant differences were observed. Within each TP, sig-
niﬁcant differences were observed between each type of
cell in most cases (p<0.05). Cell proliferation was evalu-
ated through quantiﬁcation of DNA of the cultured cells
at each period of culture (Figure 4B). The DNA concentra-
tion increased signiﬁcantly along the culture period,
except on TP_21d of the OT sample, where a signiﬁcant
decrease was observed (p<0.001). Signiﬁcant differ-
ences were observed between the three samples tested
for all the periods of culture, except on TP_1d between
SP and AJ and TP_21d between SP and OT, where no
signiﬁcant differences were observed (p>0.05).
Live/dead imaging of the different groups corroborated
the viability (MTS) and proliferation (DNA quantiﬁcation)
studies, as viable cells (green ﬂuorescence) were observed
by ﬂuorescence microscopy (Figure 5). The number of
viable cells increased from day 1 until day 21 of culture.
Cellular apoptosis was investigated by means of
performing TUNEL assay (Figure 6). This study also
corroborated the live/dead ﬁndings, as no apoptosis was
visualized, i.e. no green ﬂuorescence (upper right images)
was observed for the great majority of the cells at each
culture time.
Matrix production and deposition (i.e. proteoglycans
and collagen) was also evaluated with TB staining in each
period of culture for each specimen. No relevant matrix
deposition was observed from day 1 until day 21 in all
types of cells (Figure 7).
For performing phenotypic characterization, ankle
chondrocytes were isolated from tissue harvested from
three independent donors (mean age 26±7years). Cells
were cultured until reaching conﬂuence and trypsinized
at passages 2 and 3. Subsequently the cell population
was analysed for surface antigens by ﬂow cytometry.
Flow-cytometer calibration was based on autoﬂuorescent
expression of FITC, APC and PE by isolated chondrocytes.
The cells do not express their own ﬂuorescence at any of
the channels used, as conﬁrmed in Figure 8A for FITC
and representative for the APC and PE channels. Fluores-
cent distribution of the different chondrogenic and MSC
surface markers was evaluated at passages 2 and 3 of cell
populations. Figure 8B represents the positive ﬂuorescent
distribution of FITC and Figure 8C the absence of ﬂuores-
cence expression. The surface screening showed that cells
maintained expression of the chondrogenic surface
markers CD105, CD90, CD73, CD49f and CD44, while
showing a very low expression of MSC markers CD45
and CD34, in the living cells between passages 2 and 3,
conﬁrming the maintenance of the chondrogenic pheno-
type of the cells isolated from ankle tissues during culture
(Figure 8D).
Figure 2. 2D and 3D images of human ankle explants obtained by micro-CT analysis; OT, os trigonum; SP, Stieda’s process
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4. Discussion
In this study, the posterior process of the talus (SP), os
trigonum (OT) and normal articular ankle cartilage (AJ)
tissues and isolated cells were characterized. Cells iso-
lated from SP, OT and AJ were compared in terms of
viability and proliferation in 2D cultures, as well as in their
post-expansion extracellular matrix-forming capacity.
As previously shown in Figure S1A (see supporting in-
formation), the SP and OT structures are closely related
to the talus. Characteristically, the OT is not fused to the
talus, whereas the SP is described as a prominent elon-
gated posterolateral process of the talus (Rathur et al.,
2009). From micro-CT analysis, hard tissue and soft tissue
can be associated with bone and cartilage fractions,
respectively. In the three explants, cartilage reached ap-
proximately 50% of the total tissue content. OT showed
a higher content in cartilage tissue as compared to SP.
Our results from micro-CT morphometric analysis showed
that there is soft tissue completely surrounding the hard
tissue. Nevertheless, all the explants presented high
amounts of cartilage, which supports the hypothesis in
our study. Our ﬁndings were corroborated by the histo-
logical studies, where staining by MT and TB denoted
the presence of cartilage-like matrix. In SP1, the blue
staining was more intense than in SP2 and OT. It was
also possible to observe the appearance of typical hya-
line cartilage, with isolated and rounded chondrocytes
surrounded by the cartilaginous extracellular matrix
Figure 3. Microscopy images of the histological sections of cartilage: rows 1–4, histological stainings of cartilage extracellular matrix;
row 5, immunohistochemical localization of type II collagen; H&E, haematoxylin and eosin; TB, toluidine blue; MT, Masson’s
trichrome; Col II, type II collagen; OT, os trigonum; SP, Stieda’s process
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(Junqueira et al., 2007). On the other hand, OT and SP2
were showed to possess less hyaline cartilage content.
Fusiform chondrocytes interspersed with collagen ﬁbres
were observed in OT and SP2, which is typical of
ﬁbrocartilage. This type of cartilage presents mainly type
I collagen ﬁbres instead of the characteristic type II
collagen of hyaline cartilage. Nevertheless, type II collagen
was found in all characterized explants, as demonstrated
by immunohistochemical analysis. While no consider-
ations could bemade based on these results regarding type
I collagen deposition, it is not possible to conclude that SP2
and OT present higher amounts of ﬁbrocartilaginous tis-
sue. SP and OT did not possess higher amounts of hyaline
cartilage, which was expected, since these tissues are not
anatomically conﬁned to an articular area, where hyaline
cartilage is indicative of healthy articular cartilage.
Despite the type of cartilage present in OT or SP, the
presence of viable chondrocytes supports the study
hypothesis. Several other studies have reported the ability
of chondrocytes to produce hyaline matrix, i.e. deposition
of glycosaminoglycans and type II collagen, under
chondrogenic medium and in the presence of growth
factors (Giannini et al., 2005; Tay et al., 2004). It is known
that during monolayer expansion, chondrocytes undergo a
process of dedifferentiation, acquiring a ﬁbroblast-like
phenotype and exhibiting a certain degree of plasticity,
being able to differentiate towards the chondrogenic
phenotype in response to speciﬁc microenvironmental
factors (Barbero et al., 2006; Benya and Shaffer, 1982).
Once again, in histomorphometric analysis, the average
number of cells/mm2 in SP1 was signiﬁcantly different
(p<0.001) as compared to SP2 and OT. This corroborates
the assumption of a larger amount of hyaline cartilage in
SP1 explants, contrarily to SP2 and OT, where no signiﬁ-
cant differences (p>0.05) were observed. Due to the
typical wide matrix deposition that occurs in hyaline carti-
lage, the cells are more widely spaced, which determines a
lower cell number/mm2 tissue. Despite the observed
differences in cell numbers for the two tissues, a signiﬁcant
number of cells/area of tissue was observed and can be
isolated, supporting the idea that chondrocytes can be
obtained in enough number for possible use in regenera-
tive medicine approaches.
In this study, it was also demonstrated that it is feasible
to isolate viable chondrocytes from the SP and OT. The
in vitro studies demonstrated that isolated cells prolifer-
ated and remained metabolically active for up to 21days
of culture. In fact, a major increase in viability and
proliferation was observed from day 3 to day 7. Moreover,
between day 7 and day 14, a signiﬁcant increase
(p<0.001) in viability and proliferation was also ob-
served. As expected, the proliferation was not so expres-
sive at day 21, as a consequence of conﬂuence-induced
cell death. A decrease in DNA content was also observed
in OT isolated cells at day 21, possibly due to their high
proliferation ability, as depicted by the high DNA content
observed at day 14. These results thus showed that iso-
lated ankle cells can grow on 2D cell culture and remain
viable for at least 21days. Furthermore, not only the cells
were viable, they were also non apoptotic, as demon-
strated by the TUNEL assay. The differences observed
between SP, OT and AJ in terms of viability and prolifera-
tion within each time period, although signiﬁcant
(p<0.05), do not represent a limitation for further use
of chondrocytes isolated from these tissues. In fact, DNA
content in AJ at day 21 is signiﬁcantly inferior as compared
to SP and OT. Several studies have reported the use of AJ
chondrocytes for autologous chondrocyte implantation
(ACI) and matrix associated-cells implantation (MACI)
strategies, with promising clinical results (Aurich et al.,
2011; Correia et al., 2014; Giannini et al., 2008; Giza
et al., 2010). Aurich et al. (2011) and Giannini et al.
(2008) reported a signiﬁcant improvement in all clinical
scores after MACI and ACI procedures, respectively, using
chondrocytes isolated from AJ. In this study, isolated OT
and SP chondrocytes presented better results in terms of vi-
ability and proliferation, which indicates that chondrocytes
isolated from OT and SP could also be potentially used for
MACI and ACI procedures.
In a study comparing chondrocytes obtained from
naturally occurring ankle osteochondral defects (OCDs)
and AJ cartilage tissue, OCD chondrocytes were less
capable of appropriate extracellular matrix production
than chondrocytes from unaffected ankle joints
(Schachter et al., 2005). Also, a recent study has shown
that chondrocytes obtained from the injured zone in the
Figure 4. Evaluation of biological performance of cells isolated
from ankle tissues and cultured for 1, 3, 7, 14 and 21 days (d).
(A) Evaluation of cell viability: statistically signiﬁcant differences
were observed between time points for each sample (p< 0.05,
d> 0.8). (B) Assessment of DNA content: statistically signiﬁcant
differences were observed between time points for each sample
(p< 0.001, d> 0.8); OT, os trigonum; SP, Stieda’s process; AJ,
ankle joint; TP, time point
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ankle have inferior regenerative capacities as compared
to those from normal tissue, suggesting some reserva-
tions concerning their widespread use in the therapeutic
ﬁeld (Candrian et al., 2010). The use of healthy carti-
lage therefore seems to be more reliable to obtain good
clinical results.
In the present in vitro studies, standard culture medium
was used and no chondrogenic supplements were added.
Thus, no relevant matrix production or deposition was
observed until day 21, as expected.
Fluorescence-activated cell sorting (FACS) was per-
formed to determine the chondrogenic capacity of the iso-
lated cells, using surface chondrocyte membrane markers
(i.e. CD105, CD90, CD73, CD49f and CD44). Because
chondrocytes are the main entities for extracellular matrix
deposition in cartilage tissue, an alteration in the cellular
phenotype has an enormous signiﬁcance on the type of
matrix (Garvican et al., 2008). In the present study,
ﬂow-cytometry analysis for cell-surface screening demon-
strated that the chondrogenic markers CD105, CD90,
CD73, CD49f and CD44 are highly expressed on the sur-
face of isolated ankle human chondrocytes and did not
changed their expression during time in culture. On the
other hand, the MSCs markers CD45 and CD34 were not
detected and the lack of expression was maintained
through the culture passages. The present results conﬁrm
successful optimization of the protocol for isolation of
human chondrocytes from patients’ ankles. Moreover,
immunocytochemical analysis can be a useful technique
for detecting the deposition of matrix, as well as
distinguishing whether either of these cells are producing
type I or type II collagen during 2D culture. As already
Figure 5. Live/dead imaging of cells isolated from ankle tissues and cultured in vitro for 1–21 days (d); OT, os trigonum; SP, Stieda’s
process; AJ, ankle joint; TP, time point
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stated, the major compounds in hyaline-like cartilage
extracellular matrix are type II collagen ﬁbres and
glycosaminoglycans. Further studies should be performed
in order to evaluate matrix deposition using immunocyto-
chemistry and gene expression by quantitative real-time
reverse transcription analysis of relevant markers (e.g.
glycosaminoglycans, type I and type II collagen).
It is important to bear in mind that the in vitro experi-
mental design to characterize the post-expansion
chondrogenic capacity of ankle chondrocytes does not di-
rectly allow us to predict the in vivo reparative/
regenerative ability of the cell types, i.e. if these cells were
implanted in the talar lesions, no information is available
at this stage to safely assess their biological performance.
Thus, subsequent studies are still required prior to in vivo
use. Experiments comprising the culture of the isolated
cells from ST or OT onto a 3D porous matrix in the pres-
ence of chondrogenic inducers, either in static or
dynamic conditions, and in vivo studies using relevant
models, are future research directions that need to be
pursued as proof-of-concept.
Most of the clinical studies using MACI and ACI proce-
dures have been performed on the knee (Correia et al.,
2014), where chondrocytes are usually harvested from
healthy cartilage on the ipsilateral side. It has been shown
that ankle and knee chondrocytes have similar biosyn-
thetic activities (Candrian et al., 2009). Despite requiring
further clinical evaluation, it can be stated that the ankle
Figure 6. TUNEL assay imaging of cells isolated from ankle tissues and cultured in vitro for 1–21 days (d; small images);
counterstaining images with phalloidin (cytoskeleton) and DAPI (nuclei) are also shown (large images); OT, os trigonum; SP, Stieda’s
process; AJ, ankle joint; TP, time point; blue scale bar= 50 μm
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can be a source of viable chondrocytes for a possible
application in the treatment of cartilage lesions and OCDs
in the knee joint.
5. Conclusions
In this study, viable chondrocytes were isolated and
cultured from the posterior process of the talus (SP) and
the os trigonum (OT). This study points out a new
direction by setting up a suitable novel source of
chondrocytes (and establishing the methods for isolation
and cultivation in vitro) that can be potentially used in
cell-based and tissue-engineering strategies for the treat-
ment of cartilage and osteochondral lesions. One of the ad-
vantages of using this approach, which therefore
emphasizes the importance of this study, is that the SP
andOT tissues can be obtained by usingminimally invasive
surgical approaches, thus limiting the side-effects usually
related with the classical approaches. The results obtained
herein are promising, but further in vitro and in vivo
Figure 7. Collagen detection by toluidine blue staining on cells isolated from ankle tissues and cultured in vitro for 1–21 days (d).
Although only TP_14d and TP_21d had shown positive staining, no relevant detection of collagen was observed throughout the other
tested periods (i.e. TP_1d, TP_3d and TP_7d); OT, os trigonum; SP, Stieda’s process; AJ, ankle joint; TP, time point
Figure 8. Phenotypic evaluation of cells isolated from ankle tissues by ﬂow cytometry (FCM). Monolayer cultured cells were evalu-
ated for the expression of the human chondrogenic surface markers CD105, CD90, CD73, CD49f and CD44 and the MSC markers
CD45 and CD34. (A) FCM histogram for FITC ﬂuorescence calibration showing the absence of autoﬂuorescent expression of FITC
by human chondrocytes. (B) FCM histogram showing the ﬂuorescence intensity distribution of CD105–FITC-stained cells. (C) FCM his-
togram showing the ﬂuorescence intensity distribution of CD45–FITC-stained cells. (D) Percentage of living chondrocytes expressing
each analysed cell surface marker. Chondrocytes were obtained from three different donors and were analysed at passages 2 and 3
(n= 6 for each cell surface marker; x±SD, mean± standard deviation)
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preclinical investigations are required to determine the fea-
sibility and safety of this approach prior to its use in clinics.
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Figure S1. Scheme of the human ankle tissues, identifying the location of Stieda's process, the os trigonum (OT) and SP
after arthroscopic excision
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collagen, control sample without staining or antibodies and sample treated with type I collagen primary antibody and
AlexaFluor 488 secondary antibody
Figure S3. Cartilage cell counting within each sample
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